These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 18328578)

  • 21. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuraminidase inhibitor susceptibility surveillance of influenza viruses circulating worldwide during the 2011 Southern Hemisphere season.
    Okomo-Adhiambo M; Sleeman K; Lysén C; Nguyen HT; Xu X; Li Y; Klimov AI; Gubareva LV
    Influenza Other Respir Viruses; 2013 Sep; 7(5):645-58. PubMed ID: 23575174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants.
    Ilyushina NA; Bovin NV; Webster RG; Govorkova EA
    Antiviral Res; 2006 Jul; 70(3):121-31. PubMed ID: 16516984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased symptom severity but unchanged neuraminidase inhibitor effectiveness for A(H1N1)pdm09 in the 2010-2011 season: comparison with the previous season and with seasonal A(H3N2) and B.
    Kawai N; Ikematsu H; Kawashima T; Maeda T; Ukai H; Hirotsu N; Iwaki N; Kashiwagi S
    Influenza Other Respir Viruses; 2013 May; 7(3):448-55. PubMed ID: 22897904
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A new and rapid genotypic assay for the detection of neuraminidase inhibitor resistant influenza A viruses of subtype H1N1, H3N2, and H5N1.
    Duwe S; Schweiger B
    J Virol Methods; 2008 Nov; 153(2):134-41. PubMed ID: 18725246
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuraminidase inhibitor susceptibility profile of pandemic and seasonal influenza viruses during the 2009-2010 and 2010-2011 influenza seasons in Japan.
    Dapat C; Kondo H; Dapat IC; Baranovich T; Suzuki Y; Shobugawa Y; Saito K; Saito R; Suzuki H
    Antiviral Res; 2013 Sep; 99(3):261-9. PubMed ID: 23791870
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Influenza viruses resistant to neuraminidase inhibitors.
    Nitsch-Osuch A; Brydak LB
    Acta Biochim Pol; 2014; 61(3):505-8. PubMed ID: 25195142
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Molecular mechanisms underlying oseltamivir resistance mediated by an I117V substitution in the neuraminidase of subtype H5N1 avian influenza A viruses.
    Takano R; Kiso M; Igarashi M; Le QM; Sekijima M; Ito K; Takada A; Kawaoka Y
    J Infect Dis; 2013 Jan; 207(1):89-97. PubMed ID: 23053629
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oseltamivir resistance among influenza viruses: surveillance in northern Viet Nam, 2009-2012.
    Hoang Vu MP; Nguyen CT; Nguyen le KH; Nguyen TK; Le QM
    Western Pac Surveill Response J; 2013; 4(2):25-9. PubMed ID: 24015368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The NF-kappaB inhibitor SC75741 protects mice against highly pathogenic avian influenza A virus.
    Haasbach E; Reiling SJ; Ehrhardt C; Droebner K; Rückle A; Hrincius ER; Leban J; Strobl S; Vitt D; Ludwig S; Planz O
    Antiviral Res; 2013 Sep; 99(3):336-44. PubMed ID: 23811282
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oseltamivir resistance and the H274Y neuraminidase mutation in seasonal, pandemic and highly pathogenic influenza viruses.
    Hurt AC; Holien JK; Parker MW; Barr IG
    Drugs; 2009; 69(18):2523-31. PubMed ID: 19943705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro neuraminidase inhibitory concentration (IC
    Ikematsu H; Kawai N; Tani N; Chong Y; Bando T; Iwaki N; Kashiwagi S
    J Infect Chemother; 2020 Aug; 26(8):775-779. PubMed ID: 32249161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Influenza A H5N1 clade 2.3.4 virus with a different antiviral susceptibility profile replaced clade 1 virus in humans in northern Vietnam.
    Le MT; Wertheim HF; Nguyen HD; Taylor W; Hoang PV; Vuong CD; Nguyen HL; Nguyen HH; Nguyen TQ; Nguyen TV; Van TD; Ngoc BT; Bui TN; Nguyen BG; Nguyen LT; Luong ST; Phan PH; Pham HV; Nguyen T; Fox A; Nguyen CV; Do HQ; Crusat M; Farrar J; Nguyen HT; de Jong MD; Horby P
    PLoS One; 2008 Oct; 3(10):e3339. PubMed ID: 18836532
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children.
    Stephenson I; Democratis J; Lackenby A; McNally T; Smith J; Pareek M; Ellis J; Bermingham A; Nicholson K; Zambon M
    Clin Infect Dis; 2009 Feb; 48(4):389-96. PubMed ID: 19133796
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [H5N1 avian influenza].
    Calza L; Manfredi R; Chiodo F
    Recenti Prog Med; 2005 Nov; 96(11):523-34. PubMed ID: 16499158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Humoral immunity to influenza in an at-risk population and severe influenza cases in Russia in 2016-2017.
    Ilyicheva TN; Durymanov AG; Svyatchenko SV; Marchenko VY; Sobolev IA; Bakulina AY; Goncharova NI; Kolosova NP; Susloparov IM; Pyankova OG; Ryzhikov AB; Maksyutov RA
    Arch Virol; 2018 Oct; 163(10):2675-2685. PubMed ID: 29872951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surveillance for neuraminidase inhibitor resistance among human influenza A and B viruses circulating worldwide from 2004 to 2008.
    Sheu TG; Deyde VM; Okomo-Adhiambo M; Garten RJ; Xu X; Bright RA; Butler EN; Wallis TR; Klimov AI; Gubareva LV
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3284-92. PubMed ID: 18625765
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro and in vivo efficacy of fluorodeoxycytidine analogs against highly pathogenic avian influenza H5N1, seasonal, and pandemic H1N1 virus infections.
    Kumaki Y; Day CW; Smee DF; Morrey JD; Barnard DL
    Antiviral Res; 2011 Nov; 92(2):329-40. PubMed ID: 21925541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus.
    Schünemann HJ; Hill SR; Kakad M; Bellamy R; Uyeki TM; Hayden FG; Yazdanpanah Y; Beigel J; Chotpitayasunondh T; Del Mar C; Farrar J; Tran TH; Ozbay B; Sugaya N; Fukuda K; Shindo N; Stockman L; Vist GE; Croisier A; Nagjdaliyev A; Roth C; Thomson G; Zucker H; Oxman AD;
    Lancet Infect Dis; 2007 Jan; 7(1):21-31. PubMed ID: 17182341
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergistic effect of nitazoxanide with neuraminidase inhibitors against influenza A viruses in vitro.
    Belardo G; Cenciarelli O; La Frazia S; Rossignol JF; Santoro MG
    Antimicrob Agents Chemother; 2015 Feb; 59(2):1061-9. PubMed ID: 25451059
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.